nVerses Capital’s Acacia Research ACTG Stock Holding History

nVerses Capital’s Portfolio ACTG Stock Details ACTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,800	Closed	-$13K	–	9
2024 Q3	$13K	Buy	+2,800	New	+$13.8K	0.01%	863

Other funds holding ACTG

Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

nVerses Capital's ACTG Position: Q4 2024 in Review

nVerses Capital sold out of Acacia Research (ACTG) in Q4 2024, closing a stake of 2,800 shares — an estimated $13K sold.

nVerses Capital first reported a position in ACTG in Q3 2024 and held it in 1 quarter. The position peaked at $13K in Q3 2024. 95 funds tracked by Wall St. Rank hold ACTG as of Q4 2024.

nVerses Capital reported no remaining Acacia Research position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 2,800 Acacia Research shares in Q4 2024, an estimated $13K.
nVerses Capital first reported a position in Acacia Research in Q3 2024 and held it in 1 quarter.
nVerses Capital's Acacia Research position peaked at $13K in Q3 2024.
95 funds tracked by Wall St. Rank held Acacia Research as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.